Adjunctive Low-dose Metformin in Patients With Schizophrenia and Metabolic Abnormalities
NCT02751307
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
55
Enrollment
OTHER
Sponsor class
Conditions
Metabolic Syndrome
Interventions
DRUG:
metformin 500 mg
DRUG:
clozapine 100 mg
Sponsor
Taipei Medical University WanFang Hospital
Collaborators
[object Object]